Adeno Associated Virus Vector Manufacturing Market | USD 3.21 Billion Revenue Expected in 2030 - Growth Predictions with Bluebird Bio, Aldevron, MeiraGTx Holdings plc

kalpesh rajput

Mar 1, 2024 • 4 min read

Adeno-Associated Virus Vector Manufacturing Market Expected to Reach $3.21 Billion by 2030, Driven by Growing Gene Therapy Demand

Market Overview:

The global adeno-associated virus (AAV) vector manufacturing market is poised for significant growth, reaching an estimated $3.21 billion by 2030. This expansion is fueled by the increasing demand for gene therapies, advancements in vector engineering technologies, and a growing focus on personalized medicine.

To get the sample please click here: https://www.maximizemarketresearch.com/request-sample/189329

Report Scope:

This comprehensive report provides in-depth insights into the global AAV vector manufacturing market, covering:

Market size and growth forecasts from 2024 to 2030
Segmentation by therapy type (gene augmentation, immunotherapy, etc.), therapeutic area (neurological disorders, metabolic disorders, etc.), application (gene therapy, cell therapy, etc.), and region
Competitive landscape
Key drivers, restraints, opportunities, and challenges

Research Methodology:

A meticulous research approach was employed to ensure an accurate and detailed analysis, utilizing:

Primary data: Surveys, interviews, and interactions with industry experts
Secondary data: Research reports, company filings, government statistics, and industry publications

Segmentation:

The AAV vector manufacturing market is segmented to provide a granular view of various aspects:

By Therapy Type: Gene augmentation, Immunotherapy, Others
By Therapeutic Area: Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Muscular/Neuromuscular Disorders, Infection Disorders, Bleeding Disorders, Inflammation and Fibrosis, Others
By Application: Gene Therapy, Cell Therapy, Vaccines, Others
By End-User: Biopharmaceutical Companies, Research Institutes and Universities, Hospitals and Clinics, Others
By Region: North America, Europe, Asia Pacific, Middle East & Africa, South America

Regional Insights:

North America: Holds the dominant market share due to established players, advanced research infrastructure, and high demand for AAV vectors.
Europe: Maintains a significant presence with a strong gene therapy industry and stringent regulatory standards.
Asia Pacific: Emerges as a rapidly growing market, driven by expanding gene therapy research and increasing investments.
Other Regions: Middle East & Africa and South America experience moderate growth, but present promising opportunities due to infrastructural advancements and rising awareness about gene therapy.

Adeno Associated Virus Vector Manufacturing Market Key Players are:

1. Lonza Group Ltd. (Europe)
2. Fujifilm Diosynth Biotechnologies (North America, Europe)
3. Oxford Biomedica plc (Europe)
4. Brammer Bio (North America)
5. Cobra Biologics (Europe)
6. Thermo Fisher Scientific Inc. (North America)
7. uniQure N.V.(Europe)
8. FinVector Vision Therapies (Europe)
9. Kaneka Eurogentec S.A. (Europe)
10. MassBiologics (North America)
11. Spark Therapeutics (North America)
12. Vigene Biosciences (North America)
13. Novasep Holding SAS (Europe)
14. Bluebird Bio (North America)
15. Aldevron (North America)
16. Cell and Gene Therapy Catapult (Europe)
17. MeiraGTx Holdings plc (Europe)
18. Virovek Inc. (North America)
19. Applied Genetic Technologies Corporation (AGTC) (North America)
20. Genethon (Europe)
21. 4D Molecular Therapeutics (North America)
22. REGENXBIO Inc. (North America)
23. Fujifilm Cellular Dynamics Inc. (North America)
24. Krystal Biotech Inc. (North America)

Conclusion:

The AAV vector manufacturing market holds immense potential for continued growth, fueled by advancements in gene therapy and personalized medicine. This report provides valuable insights for stakeholders across the healthcare ecosystem, enabling strategic decision-making for future market success.

To gain deeper insights into the market analysis, explore the summary of the research report:

About Maximize Market Research:
Maximize Market Research distinguishes itself through its steadfast dedication to excellence and innovation, led by a team of seasoned professionals with extensive industry expertise. Our capabilities encompass meticulously researched insights, comprehensive technological analyses, and strategic guidance derived from thorough evaluations of competitive landscapes. Rooted in adaptability and innovation, we serve as a guiding light at the forefront of industry trends. Our commitment is dynamic, constantly evolving to meet the unique and evolving needs of our clients, ensuring that our services remain cutting-edge in an ever-changing business environment. This dedication positions us as trailblazers, adeptly navigating clients through the challenges of a dynamic market and reinforcing our leadership position. Our primary focus is on driving clients' success by delivering unparalleled value, anticipating market shifts and trends, and nurturing long-term partnerships. We strive to be more than mere service providers but trusted allies, supporting our clients' journey towards sustained success in the dynamic business landscape.

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.

⮝ 3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

✆ +91 9607365656

🖂 sales@maximizemarketresearch.com

🌐 www.maximizemarketresearch.com

More Related Report:

To gain deeper insights into the market analysis, explore the summary of the research report: https://www.maximizemarketresearch.com/market-report/adeno-associated-virus-vector-manufacturing-market/189329/